BNP Paribas Financial Markets’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-182,817
Closed -$12.4M 4256
2022
Q3
$12.4M Buy
182,817
+169,220
+1,245% +$11.5M 0.02% 593
2022
Q2
$434K Buy
13,597
+8,500
+167% +$272K ﹤0.01% 2126
2022
Q1
$177K Sell
5,097
-7,872
-61% -$273K ﹤0.01% 2613
2021
Q4
$380K Buy
12,969
+2,250
+21% +$65.9K ﹤0.01% 2520
2021
Q3
$273K Buy
10,719
+5,519
+106% +$141K ﹤0.01% 2358
2021
Q2
$182K Buy
5,200
+2,810
+118% +$98.4K ﹤0.01% 2306
2021
Q1
$97.4K Sell
2,390
-1,970
-45% -$80.3K ﹤0.01% 2807
2020
Q4
$189K Buy
4,360
+1,997
+85% +$86.5K ﹤0.01% 2277
2020
Q3
$130K Sell
2,363
-14,626
-86% -$806K ﹤0.01% 2369
2020
Q2
$1.07M Sell
16,989
-55,602
-77% -$3.51M ﹤0.01% 1279
2020
Q1
$3.71M Buy
72,591
+62,535
+622% +$3.19M 0.01% 811
2019
Q4
$799K Sell
10,056
-18,379
-65% -$1.46M ﹤0.01% 1585
2019
Q3
$1.38M Buy
28,435
+8,594
+43% +$417K ﹤0.01% 1203
2019
Q2
$1.04M Buy
19,841
+7,319
+58% +$385K ﹤0.01% 1214
2019
Q1
$663K Buy
12,522
+447
+4% +$23.7K ﹤0.01% 1416
2018
Q4
$496K Sell
12,075
-43,701
-78% -$1.79M ﹤0.01% 1233
2018
Q3
$2.12M Sell
55,776
-8,823
-14% -$335K ﹤0.01% 1004
2018
Q2
$2.92M Sell
64,599
-75,352
-54% -$3.41M ﹤0.01% 920
2018
Q1
$6.76M Buy
139,951
+132,253
+1,718% +$6.39M 0.01% 587
2017
Q4
$303K Buy
7,698
+3,353
+77% +$132K ﹤0.01% 2119
2017
Q3
$135K Sell
4,345
-202
-4% -$6.27K ﹤0.01% 2296
2017
Q2
$124K Buy
4,547
+3,975
+695% +$109K ﹤0.01% 2318
2017
Q1
$21.1K Sell
572
-719
-56% -$26.5K ﹤0.01% 2513
2016
Q4
$18.7K Sell
1,291
-138
-10% -$1.99K ﹤0.01% 2697
2016
Q3
$32.9K Buy
1,429
+874
+157% +$20.1K ﹤0.01% 2627
2016
Q2
$9.21K Buy
555
+441
+387% +$7.32K ﹤0.01% 2948
2016
Q1
$1.81K Sell
114
-1,168
-91% -$18.5K ﹤0.01% 2431
2015
Q4
$41.4K Buy
1,282
+1
+0.1% +$32 ﹤0.01% 2939
2015
Q3
$54K Buy
+1,281
New +$54K ﹤0.01% 2800